Infarction: emboli, in situ thrombosis or low flow
Haemorrhage: spontaneous (not associated with trauma). Excludes subdural and extradural haematomas, but includes spontaneous subarachnoid haemorrhage
Incidence of first ever stroke is about 200 per 100 000 per year
Prevalence is around 5-12 per 1000 population, depending on the age of the sample
It is a disease of older people (over 2/3rds of cases occur in the over 65s, less than 15% occur in under 45s)
Globally it is the third most common cause of death (after coronary heart disease and all cancers)
In England and Wales it accounts for 12% of all deaths and is the commonest cause of severe disability among community dwellers
Infarct or haemorrhage (also haemorrhagic infarcts)
Pathogenesis—large vessel, small vessel, cardioembolic (AF or LV mural thrombus), valve disease, infective endocarditis, non-atheromatous arterial disease (vasculitis, dissection), blood disorders
Vessel affected—anterior circulation (mainly middle cerebral artery), lacunar (deep small subcortical vessels), posterior circulation (vertebral and basilar arteries)
Bamford’s classification—clinical features to define likely stroke territory. Used in major trials and gives prognostic information about each group (see Table 8.1).
Table 8.1 Bamford’s classification | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Age: stroke risk increases with age (this is the strongest risk factor)
Sex: males > females
Ethnicity: higher risk in Blacks and Asians than Whites living in the West. Probably due to increased obesity, hypertension, and diabetes
Family history: positive family history increases risk. Not simple inheritance—complex genetic/environmental interaction
Previous stroke/TIA: risk of recurrence is about 10-16% in the first year, highest in the acute phase
Other vascular disease: presence of any atheromatous disease (coronary, peripheral arterial etc) increases risk of stroke
Smoking: causal and dose related. Risk diminishes 5 years after quitting
Alcohol: Conflicting evidence with some studies suggesting any alcohol consumption increases risk, while others suggest heavy drinking is a risk factor, but moderate intake is protective
Obesity: Increased risk of all vascular events in obesity—confounded by increase in other risk factors (hypertension, diabetes) but probably weak independent factor, especially central obesity
Physical inactivity: Increased stroke in less active—again confounded by presence of other risk factors in the inactive; to date limited evidence that increased activity lowers risk
Diet: Healthy eaters have lower risk, but may have healthier lifestyles in general. Low salt, high fruit and vegetable, high fish and antioxidant diets are likely to be protective, but trials have failed to show an effect from dietary interventions
Oestrogens: the oral contraceptive confers a slightly increased risk of stroke and should be avoided in the presence of other risk factors. Postmenopausal hormone replacement therapy has been shown to increase risk of ischaemic stroke, but not TIA or haemorrhagic stroke
Hypertension: clear association between increasing BP and increased stroke risk across all population groups. Risk doubles with each 5-7 mmHg increase in diastolic blood pressure. Also increases with systolic rises and even isolated systolic hypertension
Diabetes: risk factor independent of hypertension
High cholesterol: weaker risk factor than in heart disease—likely due to diversity of stroke aetiologies
Carotid stenosis: risk increases with increasing stenosis and with the occurrence of symptoms attributable to the stenosis
Other comorbidity: Increased risk in some conditions, such as sickle-cell anaemia, blood diseases causing hyperviscosity and vasculitides
Is it a focal neurological deficit?
Did it come on ‘at a stroke’ or is there a hint of progression (simple stroke may worsen over several days, but think of alternative diagnoses, eg tumour)
Is there headache or drowsiness? (haemorrhage more likely)
Was there a fall or other head trauma?
What are the vascular risk factors?
What was the premorbid state?
What are the comorbidities? (Increases chance of poor outcome)
What are the medications? (Call GP surgery if unknown)
Where do they live, and with whom? Who are the significant family members?
GCS (see Appendix, ‘Glasgow Coma Scale’, p.696). A standardized measure to assess neurological deterioration. Unconsciousness or deteriorating GCS suggests haemorrhage, large infarct with oedema or brainstem event.
NIH Stroke Scale (NIHSS). Clinical evaluation instrument with documented reliability and validity. Used to assess severity of initial stroke (when making a thrombolysis decision), outcome and degree of recovery in stroke. Grades the following areas: consciousness, orientation, obeying commands, gaze, visual fields, facial weakness, motor function in the arm and leg, limb ataxia, sensory, language, dysarthria and inattention.
General inspection (head trauma, signs of fitting—incontinence or tongue biting, frailty, and general condition, eg skin)
Temperature (especially after a long lie)
Cardiovascular examination (pulse rate and rhythm, blood pressure, cardiac examination for source of cardiac emboli, carotid bruits)
Respiratory examination (aspiration pneumonia or pre-existing respiratory conditions)
Abdominal examination (palpable bladder, organomegaly)
Neurological examination (may need to be adapted if patient drowsy)
Cranial nerves: especially visual fields and visual inattention (if difficulty with compliance, test blink response to threat, and look for a gaze preference which may occur with hemianopia or neglect), assess swallow (see ‘HOW TO … Manage swallow after stroke’, p.189)
Limbs: tone (may be diminished acutely), any weakness (grade power for later comparison). Is the distribution pyramidal—arm flexors stronger than extensors, leg extensors stronger than flexors?
If weakness subtle, assess for pyramidal/pronator drift and fine movements of both hands—(dominant should be better), coordination (limited if power is diminished), sensation (gross testing by touching both sides with eyes closed), also sensory inattention, reflexes (initially may be absent, then become brisker with time). Plantars extensor on affected side
Gait: assess in less severe stroke—is it safe? If not safe can the patient sit unaided?
Speech: dysarthria (trouble enunciating because of, eg facial weakness or posterior circulation stroke) or dysphasia (cortical disruption of speech—may be receptive and/or expressive):
Receptive dysphasia is an inability to understand language— test with one-stage commands—‘close your eyes’ and progress to more complex tasks ‘put your left hand on your right ear’. Don’t do the action yourself or the patient will copy you—a test of mimicry rather than dysphasia. If comprehension intact, reassure the patient that you know they can understand, but are having difficulty finding the right words
Expressive dysphasia—problems producing speech. May be fluent (lots of words that make no sense), or non-fluent (unrecognizable words). Nominal dysphasia is part of an expressive dysphasia and is tested by asking the patient to name increasingly rare objects, eg watch, hand, second hand)
Establish that sensory input is present bilaterally, ie check that the patient can feel a touch to each hand individually and does not have a hemianopia (may be hard to establish where extreme gaze preference exists)
Provide two stimuli at once (touch both hands together, or move fingers in both sides of the visual field) and see if the patient preferentially notices the sensory input on the good side. If so, there is inattention of the bad side
Table 8.2 The rationale for investigations in acute stroke | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|